Case reportHuman
Melanotan II injection resulting in systemic toxicity and rhabdomyolysis
Clinical toxicology (Philadelphia, Pa.), 2012 Dec. Nelson ME, Bryant SM, Aks SE.
Study type
Case report
Subjects
Human participants (PubMed MeSH: Humans)
Journal
Clinical toxicology (Philadelphia, Pa.)
Published
2012 Dec
PubMed
Where PepCue cites this
This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.
Indexed under
MeSH terms assigned by the National Library of Medicine.
Acute DiseaseAdultHumansIllicit DrugsInjections, SubcutaneousKidneyMaleMass SpectrometryPeptides, CyclicPoisoningRhabdomyolysisSkin Pigmentation
Other papers on Melanotan II
Randomized controlled trial · 2000
Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction
Clinical trial · 1998Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study
PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.
Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page